149 related articles for article (PubMed ID: 22260696)
1. The roles of ATF2 (activating transcription factor 2) in tumorigenesis.
Gozdecka M; Breitwieser W
Biochem Soc Trans; 2012 Feb; 40(1):230-4. PubMed ID: 22260696
[TBL] [Abstract][Full Text] [Related]
2. High levels of phosphorylated c-Jun, Fra-1, Fra-2 and ATF-2 proteins correlate with malignant phenotypes in the multistage mouse skin carcinogenesis model.
Zoumpourlis V; Papassava P; Linardopoulos S; Gillespie D; Balmain A; Pintzas A
Oncogene; 2000 Aug; 19(35):4011-21. PubMed ID: 10962557
[TBL] [Abstract][Full Text] [Related]
3. Sensitisation of c-MYC-induced B-lymphoma cells to apoptosis by ATF2.
Walczynski J; Lyons S; Jones N; Breitwieser W
Oncogene; 2014 Feb; 33(8):1027-36. PubMed ID: 23416976
[TBL] [Abstract][Full Text] [Related]
4. TGF-beta-induced transcriptional activation of MMP-2 is mediated by activating transcription factor (ATF)2 in human breast epithelial cells.
Kim ES; Sohn YW; Moon A
Cancer Lett; 2007 Jul; 252(1):147-56. PubMed ID: 17258390
[TBL] [Abstract][Full Text] [Related]
5. Jun signalling in the epidermis: From developmental defects to psoriasis and skin tumors.
Zenz R; Wagner EF
Int J Biochem Cell Biol; 2006; 38(7):1043-9. PubMed ID: 16423552
[TBL] [Abstract][Full Text] [Related]
6. Activation of extracellular signal-regulated kinase and c-Jun-NH(2)-terminal kinase but not p38 mitogen-activated protein kinases is required for RRR-alpha-tocopheryl succinate-induced apoptosis of human breast cancer cells.
Yu W; Liao QY; Hantash FM; Sanders BG; Kline K
Cancer Res; 2001 Sep; 61(17):6569-76. PubMed ID: 11522656
[TBL] [Abstract][Full Text] [Related]
7. Distinct roles of Jun : Fos and Jun : ATF dimers in oncogenesis.
van Dam H; Castellazzi M
Oncogene; 2001 Apr; 20(19):2453-64. PubMed ID: 11402340
[TBL] [Abstract][Full Text] [Related]
8. Identification of a c-Jun N-terminal kinase-2-dependent signal amplification cascade that regulates c-Myc levels in ras transformation.
Mathiasen DP; Egebjerg C; Andersen SH; Rafn B; Puustinen P; Khanna A; Daugaard M; Valo E; Tuomela S; Bøttzauw T; Nielsen CF; Willumsen BM; Hautaniemi S; Lahesmaa R; Westermarck J; Jäättelä M; Kallunki T
Oncogene; 2012 Jan; 31(3):390-401. PubMed ID: 21706057
[TBL] [Abstract][Full Text] [Related]
9. Alteration of activator protein 1 DNA binding activity in gentamicin-induced hair cell degeneration.
Albinger-Hegyi A; Hegyi I; Nagy I; Bodmer M; Schmid S; Bodmer D
Neuroscience; 2006 Feb; 137(3):971-80. PubMed ID: 16338090
[TBL] [Abstract][Full Text] [Related]
10. The transcription factor ATF-2 inhibits extracellular signal regulated kinase expression and proliferation of human cancer cells.
Crowe DL; Shemirani B
Anticancer Res; 2000; 20(5A):2945-9. PubMed ID: 11062705
[TBL] [Abstract][Full Text] [Related]
11. Active, phosphorylation-dependent MAP kinases, MAPK/ERK, SAPK/JNK and p38, and specific transcription factor substrates are differentially expressed following systemic administration of kainic acid to the adult rat.
Ferrer I; Blanco R; Carmona M; Puig B; Domínguez I; Viñals F
Acta Neuropathol; 2002 Apr; 103(4):391-407. PubMed ID: 11904760
[TBL] [Abstract][Full Text] [Related]
12. Early modifications in the expression of mitogen-activated protein kinase (MAPK/ERK), stress-activated kinases SAPK/JNK and p38, and their phosphorylated substrates following focal cerebral ischemia.
Ferrer I; Friguls B; Dalfó E; Planas AM
Acta Neuropathol; 2003 May; 105(5):425-37. PubMed ID: 12677442
[TBL] [Abstract][Full Text] [Related]
13. Complex functions of AP-1 transcription factors in differentiation and survival of PC12 cells.
Leppä S; Eriksson M; Saffrich R; Ansorge W; Bohmann D
Mol Cell Biol; 2001 Jul; 21(13):4369-78. PubMed ID: 11390664
[TBL] [Abstract][Full Text] [Related]
14. B-ATF functions as a negative regulator of AP-1 mediated transcription and blocks cellular transformation by Ras and Fos.
Echlin DR; Tae HJ; Mitin N; Taparowsky EJ
Oncogene; 2000 Mar; 19(14):1752-63. PubMed ID: 10777209
[TBL] [Abstract][Full Text] [Related]
15. Pro-inflammatory cytokines stimulate mitogen-activated protein kinase subfamilies, increase phosphorylation of c-Jun and ATF2 and upregulate c-Jun protein in neonatal rat ventricular myocytes.
Clerk A; Harrison JG; Long CS; Sugden PH
J Mol Cell Cardiol; 1999 Dec; 31(12):2087-99. PubMed ID: 10640438
[TBL] [Abstract][Full Text] [Related]
16. Activation of activating transcription factor 2 by p38 MAP kinase during apoptosis induced by human amylin in cultured pancreatic beta-cells.
Zhang S; Liu H; Liu J; Tse CA; Dragunow M; Cooper GJ
FEBS J; 2006 Aug; 273(16):3779-91. PubMed ID: 16869889
[TBL] [Abstract][Full Text] [Related]
17. The role of ATF-2 in oncogenesis.
Vlahopoulos SA; Logotheti S; Mikas D; Giarika A; Gorgoulis V; Zoumpourlis V
Bioessays; 2008 Apr; 30(4):314-27. PubMed ID: 18348191
[TBL] [Abstract][Full Text] [Related]
18. CARMA1- and MyD88-dependent activation of Jun/ATF-type AP-1 complexes is a hallmark of ABC diffuse large B-cell lymphomas.
Juilland M; Gonzalez M; Erdmann T; Banz Y; Jevnikar Z; Hailfinger S; Tzankov A; Grau M; Lenz G; Novak U; Thome M
Blood; 2016 Apr; 127(14):1780-9. PubMed ID: 26747248
[TBL] [Abstract][Full Text] [Related]
19. Regulation of gene transcription by a constitutively active mutant of activating transcription factor 2 (ATF2).
Steinmüller L; Thiel G
Biol Chem; 2003 Apr; 384(4):667-72. PubMed ID: 12751796
[TBL] [Abstract][Full Text] [Related]
20. AP-1 and ATF-2 are constitutively activated via the JNK pathway in Theileria parva-transformed T-cells.
Botteron C; Dobbelaere D
Biochem Biophys Res Commun; 1998 May; 246(2):418-21. PubMed ID: 9610375
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]